Cramer预计这款金融科技将达到100美元，对Eli Lilly感到不安：'回来和我谈谈'

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Affirm Holdings Inc (NASDAQ:AFRM) is a buy. “It's at $72, it's going to $100,” he noted.

On the earnings front, Affirm will announce its fourth quarter fiscal year results after the closing bell on Aug. 28.

When asked about Eli Lilly And Co (NYSE:LLY), he said, “Down here, I begin to think that we are too negative on it. But I am very upset with Lilly and the way they handled this, and I think they should come back on and talk to me.”

As per the recent news, Eli Lilly, on Aug. 7, released topline data from the Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist.

“I don't want to be connected with Brazil,” Cramer said when asked about Banco Bradesco SA (NYSE:BBD). “It's had a big run. If you want an overseas bank, I think you should be in Santander.”

On May 28, Citigroup analyst Rafael Frade upgraded Bank Bradesco from Neutral to Buy.

Cramer said, “I think longer term, ServiceNow (NYSE:NOW) has really good AI, and it would not be a stock that I would want to bet against. So, ServiceNow longer term I think is fine. Shorter term I think it's going to be under pressure.”

ServiceNow, on July 23, reported second-quarter revenue of approximately $3.22 billion, beating the consensus estimate of $3.12 billion, according to Benzinga Pro. The company reported second-quarter adjusted earnings of $4.09 per share, beating analyst estimates of $3.57 per share.

Price Action:

• Eli Lilly shares gained 1.5% to settle at $635.22 on Monday.
• Affirm shares rose 0.9% to settle at $72.97.
• Banco Bradesco shares closed at $2.90 on Monday.
• ServiceNow shares declined 1.9% to close at $856.37.

Read Next:

• Top 2 Real Estate Stocks That May Collapse In Q3

Image: Shutterstock